Dyskalemia Prior to and After Initiation of a Fixed Dose Combination of Telmisartan and Amlodipine in Adults with Hypertension in Bangladesh
Global Heart2025Vol. 20(1), pp. 30–30
Citations Over TimeTop 21% of 2025 papers
Junichi Ishigami, Md. Mahmudul Hasan, Aruna Sarker, Sharmin Nahar, Sohul Shuvo, Mir Ishraquzzaman, Mohammad Abdullah Al Mamun, Md Kalimuddin, Sheikh Mohammad Mahbubus Sobhan, Di Zhao, Kunihiro Matsushita, Lawrence J. Appel, Sohel Reza Choudhury, Edgar R. Miller, Fazila‐Tun‐Nesa Malik
Abstract
Given low prevalence and incidence of hyperkalemia and evident reduction in BP, our study suggests initiating FDC with telmisartan and amlodipine may be a practical and safe option for newly diagnosed hypertension, especially in resource-constrained settings where blood tests cannot be easily obtained.
Related Papers
- → Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes(2017)128 cited
- → Disorders of Potassium Balance(2009)11 cited
- → The mechanism and management of hyperkalemia and hypokalemia in children(2016)1 cited
- → Hyperkalemia/Hypokalemia(2017)
- → Prevalence and Clinical Profile of Hypokalemia and Hyperkalemia in Admitted Patients of General Medicine Department at a Tertiary Care Centre of Bihar(2022)